Reason for request
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
rjME8KC20hNQWa3c
